As a global leading animal model business service company, Cyagen provides major gene knockout (KO), gene knockin (KI), conditional knockout (cKO), and other model customization services in superior quality and full guarantee. Additionally, combining self-development and introduction, Cyagen has already established its pharmaceutical R&D line - catering to drug development and screening in the field of cancer, immunity, endocrine system, cardiovascular system, and infectious diseases, etc. With the aim of business expansion, the company further developed with antibody drug development platform on humanized mouse antibodies basis, as well as built sterile-mice-based microbial drug R&D technology platform, and platform for mouse phenotype analysis. The company and its products and services have been cited in over 3,800 papers cross highly reputed publications and journals including Cell, Nature, Science and more - all in under 15 years.